About Awamedica

Introduction

 Awamedica is a privately held pharmaceuticals company located in Erbil, Iraq. The company is in every respect an international company. It is built with Swedish expertise and with Swedish quality.

Awamedica has a partnership with the French multinational company Sanofi, manufacturing several of Sanofi’s most well-known products for the Iraqi market.

Mission

Awamedica develops, produces, markets and sells a broad range of medicines catering for the needs of the Iraqi market and beyond.

The customers, both public and private, are offered affordable products of a quality that is of the highest international standard, thereby ensuring both efficacy and safety for the patient.

Vision

Committed to Quality, Awamedica is perceived to be the regional leader in all aspects of quality.

Quality Assurance

Awamedica is compliant with current Good Manufacturing Practice (cGMP) as confirmed by regulatory authorities and international company audits. Our Quality Control and Quality Assurance personnel are highly qualified and with long experience from the industry in many countries.

Raw materials are acquired from many countries. Awamedica only works with suppliers that have standards consistent with Awamedica’s own.

Marketing and Sales

The private market is reached through Awamedica’s own sales force covering the Kurdistan Region of Iraq as well as Baghdad with surrounding areas.

Kimadia, the Ministry of Health in Baghdad procurement organization, is a major customer for Awamedica. The company is every year successfully winning a great number of Kimadia tenders.

As part of its quality commitment to patients Awamedica prints its product information leaflets and other information material in three languages, English, Kurdish and Arabic.

Product Development and Products

Awamedica is one of the few companies in the region that makes its own product development and formulation, using a state of the art laboratory and pilot plant.

The products are in the form of tablets, capsules, liquids, dry syrups for reconstitution and semi solids such as ointments and creams.

Awamedica’s products cover the therapeutic areas of gastroenterology, cardiovascular and pulmonary diseases as well as infections, diabetes, allergy and pain.

Production facilities


The facility is 13000 m2, compliant with cGMP requirements. Awamedica manufactures:

  • Solid Orals as tablets (coated tablets, sustained release tablets, fast melt tablets, prolonged release tablets) and capsules.
  • Liquid Orals as syrups.
  • Dry Powder.
  • Semi-solids as creams, ointments and gels.

Awamedica is working with the latest technology in manufacturing with a separate formulation and development department having a full equipped pilot plant.

Yearly capacity for one shift (8 hours/day)

Production Line Units
Tablets 2.4 billion
Capsules 200 million
Liquids 10.0 million bottles
Ointments & Creams 10.0 million tubes
Dry syrups 8.0 million bottles

 Production of Tablets and capsules is in access of 20 million packs per year.

Staff

Awamedica has more than two hundred employees, local and international. They represent six different countries, from Sweden in the north to Zambia in the south. More than twenty employees have a university degree in pharmacy or chemistry.

Internal training programs make sure that all staff meets the highest international industry standards.